The ESTERN Medical Therapeutic Expertise group delivers unparalleled scientific and medical proficiency dedicated to advancing clinical development.
Our esteemed panel comprises board-certified physicians, clinical industry mavens, and institutions certified by regulatory agencies, ensuring the capacity to conduct clinical trials sanctioned by international bodies or the Ministry of Health (MOH).
Encompassing an extensive array of therapeutic domains, our group empowers ESTERN Medical staff with meticulous training and unwavering support during the operational delivery of clinical services.
We cater to all phases of drug development, with a specialized focus on trial design, clinical monitoring, and regulatory submission strategies.
Distinguished by our profound understanding of therapeutic landscapes, we navigate through Cardiology, Interventional Cardiology and Radiology, Oncology, CNS, Pain Management Psychiatry, Infectious Diseases, Ophthalmology, and Diagnostic Radiological Imaging (CT/MRA & MRI), as well as Rare Diseases & Orphan Diseases.
ESTERN Medical’s therapeutic purview spans pivotal trials and traverses the complexities of Clinical trial Phases I, II, III through Phase IV. Our expansive portfolio includes a multitude of global international clinical trial studies conducted across North America and Latin America, including Mexico, Colombia, Chile, Peru, Argentina, and Brazil.
Our proficiency in diverse therapeutic areas is fortified by seasoned senior management and staff members and distinguished connoisseurs in clinical pharmaceutical and medical device development. Leveraging our access to key opinion leaders (KOLs) and trial networks globally, an extensive proprietary investigator database, and global operational expertise, we seamlessly conduct multi-national trials in the “US-North America & Latin American emerging markets.”
Successfully managing a myriad of clinical trials across all phases of development in the US, North America, and Latin America (LATAM) emerging markets, ESTERN Medical excels in patient recruitment from targeted populations within our core therapeutic areas of expertise.
Our in-depth feasibility assessments significantly mitigate risks and enhance the probability of study/program success. Esteemed relationships with key opinion leaders worldwide provide us with invaluable insights into local country knowledge, ensuring optimal trial planning and execution by understanding local regulatory environments, customs, and other influencing factors.
Beyond supporting every trial conducted by ESTERN Medical, our therapeutic experts offer stand-alone consulting services, including:
– Clinical development program and protocol design
– Integration of scientific/clinical, regulatory, and economic development needs
– Formation and membership of Scientific Advisory Boards
– Development and management of DSMB charters
– Training for core team members (e.g., CRAs, Project Managers, Clinicians, Scientists, Physicians) covering:
– Disease background
– Current standard of care and alternative treatment options
– Basic diagnostics
– Patient safety
– Trial specifics, ensuring comprehensive fulfillment of investigators’ and clients’ needs.
